Automated Insulin Dosing Device System, Single Hormonal Control
Adverse-event figures are drawn from the U.S. Food & Drug Administration (FDA) MAUDE database, refreshed March 2026, see our methodology.
OpenFDA device adverse-event casebook.
FDA MAUDE casebook
openFDA event book Automated Insulin Dosing Device System HEAVY-BOOK · MAUDE
#6 of 1000 · 885,752 reports · 2015–2026
- BOOK 885,752 reports
- RANK #6 of 1000
- DEATH 1,254 death-typed
- INJ 127,210 injury-typed
- MALF 757,285 malfunction
- SPAN 2015–2026
- PEAK 2022: 154,932
- PHOTO Pump
Nearest event-volume peer: Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor (4,787 report gap)
Automated Insulin Dosing Device System, Single Hormonal Control sits #6 of 1000 among tracked device types with 885,752 MAUDE reports spanning 2015–2026. Rank counts report volume, not confirmed device fault. Event_type Death / Injury / Malfunction are one code per report — not the same population as patient-outcome rows ( methodology). Read with this device → · Lead manufacturer → · Similar-volume device →
Malfunction reports run above the device-type norm
Automated Insulin Dosing Device System carries 85.5% MALFUNCTION-coded reports, 20.7pp above the 1,000-device-type mean, the widest gap of its three event codes. Codes are report labels, not adjudicated causation.
- DEATH 0.1% corpus 1.5% · below corpus mean (-1.4 pp)
- INJ 14.4% corpus 30.3% · below corpus mean (-15.9 pp)
- MALF 85.5% corpus 64.8% · above corpus mean (+20.7 pp)
Lead product-problem code Break is 13% of coded problems · Lead manufacturer MEDTRONIC PUERTO RICO OPERATIONS CO. accounts for 90% of manufacturer-tagged reports · Top event location is 85% of location-tagged rows .
Automated Insulin Dosing Device System in the event-volume neighbourhood
FDA MAUDE report totals among this device type and nearest nationwide peers
- Alternate Con…
Alternate Controller Enabled Insulin Infusion Pump
1,260,826 reports
- Pump
Pump, Infusion, Insulin, To Be Used With Invasive Glucose Sensor
890,539 reports
- Automated Ins… (this)
Automated Insulin Dosing Device System, Single Hormonal Control
885,752 reports
- Pump
Pump, Infusion, Insulin
539,077 reports
- Automated Ins… 439,398
Automated Insulin Dosing , Threshold Suspend
439,398 reports
- System 431,358
System, Test, Blood Glucose, Over The Counter
431,358 reports
What this shows Automated Insulin Dosing Device System, Single Hormonal Control carries 885,752 MAUDE reports, ranked #6 of 1000.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Top Product Problems
Yearly Trend
Reports in 2025 (152,969) held close to the prior two-year average of 137,395.
Related Entities for Automated Insulin Dosing Device System, Single Hormonal Control
Top Manufacturers
Event Locations
Compare MEDTRONIC PUERTO RICO OPERATIONS CO. vs MEDTRONIC MINIMED →
Nationwide devices with a comparable volume-and-death footprint
Two openFDA-derived peer sets for Automated Insulin Dosing Device System: nearest by total report volume and nearest by death-typed count, each floored at ≥100 reports so the neighborhoods stay in the advertised mass.
Similar report volume
Nearest other device types by FDA MAUDE report count (885,752 here).
Similar death-typed counts
Nearest other device types by death-typed report count (1,254 here), distinct from the volume row.
Read our methodology - how this data is sourced, computed, and verified.
Disclaimer: MAUDE figures for Automated Insulin Dosing Device System are informational only and are not clinical advice. Report codes do not prove device causation. Consult a qualified clinician before acting on this data.
Every figure on PlainHospital is rendered directly from federal source data, no number is typed in by an editor. Event-type mix on this page is computed from FDA MAUDE codes for Automated Insulin Dosing Device System; corpus means use device types with ≥100 reports. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.